Cover Image
市場調查報告書

全球肝炎診斷檢驗市場:各檢驗類型(血液檢驗(肝功能檢驗,免疫測量,核酸檢驗),影像檢查,肝臟切片檢查),地區的預測 2014年∼2025年

Hepatitis Diagnostic Test Market Analysis Report, By Diagnostic Tests {Blood Tests (Liver Function Assays, Immunoassays & Nucleic Acid Assays), Imaging Tests & Liver Biopsy}, By Region, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 615518
出版日期 內容資訊 英文 90 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球肝炎診斷檢驗市場:各檢驗類型(血液檢驗(肝功能檢驗,免疫測量,核酸檢驗),影像檢查,肝臟切片檢查),地區的預測 2014年∼2025年 Hepatitis Diagnostic Test Market Analysis Report, By Diagnostic Tests {Blood Tests (Liver Function Assays, Immunoassays & Nucleic Acid Assays), Imaging Tests & Liver Biopsy}, By Region, And Segment Forecasts, 2014 - 2025
出版日期: 2018年01月25日 內容資訊: 英文 90 Pages
簡介

全球肝炎診斷檢驗市場,至2025年成長到69億美元規模的市場。與D型、E型肝炎比較,A型、B型、C型肝炎有增加趨勢,根據世界衛生組織(WHO)報告,開發中國家兒童有90%,10歲之前感染A型肝炎。還有2016年的資料,全球整體有2億5,700萬人患B型肝炎,7,100萬人患C型肝炎。對肝炎篩檢和監測的關心增加,及肝炎的罹患率上升,迅速檢驗技術的需求高漲等,成為這個市場主要的促進成長因素。

本報告提供全球肝炎診斷檢驗市場調查,市場概要,各檢驗類型、地區的市場趨勢,市場規模的變化與預測,市場佔有率,成長要素及阻礙因素分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 調查方法

  • 資訊採購
  • 資料分析
  • 調查資料的清單

第2章 摘要整理

  • 市場概要

第3章 市場變數,趨勢,範圍

  • 市場區隔和規模
  • 普及與成長預測製圖
  • PESTEL分析
  • 波特的五力分析

第4章 肝炎診斷檢驗市場預測與趨勢分析:各檢驗類型

  • 各檢驗類型的市場趨勢
  • 血液檢驗
    • 肝功能檢驗
    • 免疫測量
    • 核酸檢驗
  • 影像檢查
  • 肝臟切片檢查

第5章 肝炎診斷檢驗市場預測與趨勢分析:各地區

  • 各地區的市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲地區

第6章 競爭情形

  • 企業簡介
    • Siemens AG
    • Abbott Laboratories
    • MedMira Inc
    • Qaigen Inc
    • Beckman Coulter Inc (Danaher Corporation)
    • F. Hoffmann Roche
    • Diasorin S.p.A
    • bioMeriuex
    • bioMeriuex
    • Bio-Rad Laboratories Inc
目錄
Product Code: GVR-1-68038-449-9

The global hepatitis diagnostics test market is expected to reach USD 6.9 billion by 2025, according to a new report by Grand View Research, Inc. The rise in cases of hepatitis A, B & C is prominent as compared to D & E. World Health Organization (WHO), reports state 90% of children (before the age of 10 years), in developing countries are infected with hepatitis A virus. The reports by the WHO also states that 257 million people were suffering from hepatitis B virus infection, and 71 million people were affected by the hepatitis C in 2016.

The government, NGOs and non-profitable organizations play an important role in creating awareness of diseases by providing correct information about the condition, symptoms and detection techniques. Rise in awareness regarding the disease is positively impacting the market growth with increase in demand for diagnostic tests. Also, the technological developments such as molecular diagnostics involving DNA and RNA testing is contributing in the market growth.

Hence, factors such as rising awareness regarding availability of screening and monitoring procedures, growing prevalence of hepatitis and increasing demand for rapid diagnostic techniques are expected to propel the global market over the forecast period.

Further key findings from the study suggest:

  • The growing prevalence rate of hepatitis (A, B, C, D & E) is primarily driving the market growth
  • The blood tests segment is further segmented in to liver function tests, immunoassays & nucleic acid assays
  • The blood tests dominate the market and are expected to exhibit fastest growth rate over the forecast period, owing to their affordability and higher adoption volume as compared to other tests
  • The liver function tests hold a significant share of the market since these tests are the first line diagnostics and are prerequisite for further analytical examinations required to be performed for confirmation of virus causing the disease
  • North America dominated in 2016, owing to rising prevalence, various government initiatives creating awareness regarding rising incidences, treatment & availability of diagnostic test options, and highly developed healthcare infrastructure
  • Constant rise in the new cases of hepatitis is observed in Asia Pacific. Thus, this region is expected to witness a rapid growth during the forecast period.
  • Some of the major players competing include, but are not limited to Abbott Laboratories; Danaher Corporation; F. Hoffmann Roche; DiaSorin S.p.A; MedMira, Inc.; Siemens Ag, bioMeriuex SA; Hologic, Inc.; and Bio Rad Laboratories.
  • These players dominate the market with their strong brand identity and extensive geographic reach by their strategic initiatives such as mergers & acquisition and partnership with other players.

Table of Contents

Chapter 1: Research Methodology

  • 1.1 Information procurement
  • 1.2 Data Analysis
  • 1.3 List of Data Sources

Chapter 2: Executive Summary

  • 2.1 Market Snapshot

Chapter 3: Hepatitis Diagnostic Market Variables, Trends & Scope

  • 3.1 Market segmentation& scope
    • 3.1.1 Market Driver Analysis
    • 3.1.2 Market Restraint Analysis
  • 3.2 Penetration & growth prospect mapping
  • 3.3 Hepatitis Diagnostics Market - PESTLE Analysis
  • 3.4 Industry Analysis - Porter's

Chapter 4: Hepatitis Diagnostic Market: Test Type Estimates & Trend Analysis

  • 4.1 Hepatitis diagnostics market: Tests type movement analysis
  • 4.2 Blood Tests
    • 4.2.1 Blood Tests market estimates & segment forecast, 2014 - 2025 (USD Million)
    • 4.2.2 Liver Function Tests
      • 4.2.2.1 L Market estimates & segment forecast, 2014 - 2025 (USD Million)
    • 4.2.3 Immunoassays
      • 4.2.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
    • 4.2.4 Nucleic Acid Tests
      • 4.2.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
  • 4.3 Imaging Test
    • 4.3.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)
  • 4.4 Liver Biopsy
    • 4.4.1 Market estimates & segment forecast, 2014 - 2025 (USD Million)

Chapter 5: Hepatitis Diagnostic Market: Regional Estimates & Trend Analysis, by Diagnostic Tests

  • 5.1 Hepatitis Diagnostic market share by region, 2015 & 2024
  • 5.2 North America
    • 5.2.1 North America hepatitis diagnostics market, 2014 - 2025 (USD Million)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. hepatitis diagnostics market, 2014 - 2025 (USD Million)
    • 5.2.3 Canada
      • 5.2.3.1 Canada hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe hepatitis diagnostics market, 2014 - 2025 (USD Million)
    • 5.3.2 UK
      • 5.3.2.1 UK hepatitis diagnostics market, 2014 - 2025 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Germany hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific hepatitis diagnostic market, 2014 - 2025 (USD Million)
    • 5.4.2 China
      • 5.4.2.1 China hepatitis diagnostic market, 2014 - 2025 (USD Million)
    • 5.4.3 Japan
      • 5.4.3.1 Japan hepatitis diagnostic market, 2014 - 2025 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Latin America hepatitis diagnostics market, 2014 - 2025 (USD Million)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil hepatitis diagnosticmarket, 2014 - 2025 (USD Million)
    • 5.5.3 Mexico
      • 5.5.3.1 Mexico hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • 5.6 MEA
    • 5.6.1 MEA hepatitis diagnostics market, 2014 - 2025 (USD Million)
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa hepatitis diagnostics market, 2014 - 2025 (USD Million)

Chapter 6: Competitive Landscape

  • 6.1 Company Profiles
    • 6.1.1 Siemens AG
      • 6.1.1.1 Company overview
      • 6.1.1.2 Financial performance
      • 6.1.1.3 Product benchmarking
      • 6.1.1.4 Strategic initiatives
    • 6.1.2 Abbott Laboratories
      • 6.1.2.1 Company overview
      • 6.1.2.2 Financial performance
      • 6.1.2.3 Product benchmarking
      • 6.1.2.4 Strategic initiatives
    • 6.1.3 MedMira Inc
      • 6.1.3.1 Company overview
      • 6.1.3.2 Financial performance
      • 6.1.3.3 Product benchmarking
      • 6.1.3.4 Strategic initiatives
    • 6.1.4 Qaigen Inc
      • 6.1.4.1 Company overview
      • 6.1.4.2 Financial performance
      • 6.1.4.3 Product benchmarking
      • 6.1.4.4 Strategic initiatives
    • 6.1.5 Beckman Coulter Inc (Danaher Corporation)
      • 6.1.5.1 Company overview
      • 6.1.5.2 Financial performance
      • 6.1.5.3 Product benchmarking
      • 6.1.5.4 Strategic initiatives
    • 6.1.6 F. Hoffmann Roche
      • 6.1.6.1 Company overview
      • 6.1.6.2 Financial performance
      • 6.1.6.3 Product benchmarking
      • 6.1.6.4 Strategic initiatives
    • 6.1.7 Diasorin S.p.A
      • 6.1.7.1 Company overview
      • 6.1.7.2 Financial performance
      • 6.1.7.3 Product benchmarking
      • 6.1.7.4 Strategic initiatives
    • 6.1.8 bioMeriuex
      • 6.1.8.1 Company overview
      • 6.1.8.2 Financial performance
      • 6.1.8.3 Product benchmarking
      • 6.1.8.4 Strategic initiatives
    • 6.1.9 Hologic Inc
      • 6.1.9.1 Company overview
      • 6.1.9.2 Financial performance
      • 6.1.9.3 Product benchmarking
      • 6.1.9.4 Strategic initiatives
    • 6.1.10 Bio-Rad Laboratories Inc
      • 6.1.10.1 Company overview
      • 6.1.10.2 Financial performance
      • 6.1.10.3 Product benchmarking
      • 6.1.10.4 Strategic initiatives

List of Tables

  • TABLE 1 North America Hepatitis Diagnostics Market, by Test Type, 2014 - 2025 (USD Million)
  • TABLE 2 North America Hepatitis Diagnostics Market, by Blood Tests Market, 2014 - 2025 (USD Million)
  • TABLE 3 U.S. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 4 U.S. hepatitis diagnostics market, by blood tests, 2014 - 2025 (USD Million)
  • TABLE 5 Canada hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 6 Canada hepatitis diagnostic, by blood tests, 2014 - 2025 (USD Million)
  • TABLE 7 Europe hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 8 Europe hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 9 U.K. hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 10 U.K. hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 11 Germany hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 12 Germany hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 13 Asia Pacific hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 14 Asia Pacific hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 15 China hepatitis diagnostic market, by test type, 2014 - 2025 (USD Million)
  • TABLE 16 China hepatitis diagnostic tests market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 17 Japan hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 18 Japan hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 19 Latin America hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 20 Latin America hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 21 Brazil hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
  • TABLE 22 Brazil hepatitis diagnostic market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 23 Mexico hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
  • TABLE 24 Mexico hepatitis diagnostics market, by blood tests, 2014 - 2025 (USD Million)
  • TABLE 25 MEA hepatitis diagnostics market, by test type, 2014 - 2025 (USD Million)
  • TABLE 26 MEA hepatitis diagnostics market, by blood tests 2014 - 2025 (USD Million)
  • TABLE 27 South Africa hepatitis diagnostics market, by test type , 2014 - 2025 (USD Million)
  • TABLE 28 South Africa hepatitis diagnostics market, by blood test 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 Hepatitis Diagnostic s Market PESTLE Analysis
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Hepatitis Diagnostics market drug class outlook key takeaways
  • FIG. 16 Hepatitis diagnostic market: test type movement analysis
  • FIG. 17 Blood test market estimates & segment forecast, 2014 - 2025 (USD Million)
  • FIG. 18 Liver function tests market estimates & segment forecast market, 2014 - 2025 (USD Million)
  • FIG. 19 Immunoassay market estimates & segment forecast, 2014 - 2025 (USD Million)
  • FIG. 20 Nucleic Tests market estimates & segment forecast, 2014 - 2025 (USD Million)
  • FIG. 21 Imaging test market estimates & segment forecast, 2014 - 2025 (USD Million)
  • FIG. 22 Liver Biopsy market estimates & segment forecast, 2014 - 2025 (USD Million)
  • FIG. 23 Regional market place: Key takeaways
  • FIG. 24 Regional outlook, 2016 & 2025
  • FIG. 25 North America hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 26 U.S. hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 27 Canada hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 28 Europe hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 29 UK hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 30 Germany hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 31 Asia Pacific hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 32 China hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 33 Japan hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 34 Latin America hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 35 Brazil hepatitis diagnostics market, 2014 - 2025(USD Million)
  • FIG. 36 Mexico hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 37 MEA hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 38 South Africa hepatitis diagnostics market, 2014 - 2025 (USD Million)
  • FIG. 39 Strategy framework
  • FIG. 40 Participant categorization
Back to Top